State Board of Administration of Florida Retirement System’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.37M Buy
73,222
+815
+1% +$49.2K 0.01% 755
2026
Q1
$2.92M Hold
72,407
0.01% 922
2025
Q4
$2.52M Buy
72,407
+9,340
+15% +$734K ﹤0.01% 971
2025
Q3
$5.24M Buy
63,067
+4,471
+8% +$324K 0.01% 785
2025
Q2
$4.3M Buy
58,596
+35,539
+154% +$2.58M 0.01% 840
2025
Q1
$2.63M Sell
23,057
-44,849
-66% -$2.73M 0.01% 927
2024
Q4
$3.42M Sell
67,906
-17,911
-21% -$939K 0.01% 883
2024
Q3
$3.97M Buy
85,817
+62,760
+272% +$2.23M 0.01% 856
2024
Q2
$749K Sell
23,057
-43,809
-66% -$1.2M ﹤0.01% 1313
2024
Q1
$1.45M Buy
66,866
+43,809
+190% +$1.04M ﹤0.01% 1048
2023
Q4
$749K Sell
23,057
-36,839
-62% -$1.01M ﹤0.01% 1390
2023
Q3
$1.63M Buy
59,896
+270
+0.5% +$7.81K ﹤0.01% 1038
2023
Q2
$1.33M Sell
59,626
-7,240
-11% -$167K ﹤0.01% 1103
2023
Q1
$1.45M Buy
66,866
+36,839
+123% +$808K ﹤0.01% 1082
2022
Q4
$610K Sell
30,027
-43,640
-59% -$1.09M ﹤0.01% 1479
2022
Q3
$1.89M Buy
73,667
+30,000
+69% +$803K ﹤0.01% 1005
2022
Q2
$1.04M Hold
43,667
﹤0.01% 1243
2022
Q1
$983K Hold
43,667
﹤0.01% 1373
2021
Q4
$865K Sell
43,667
-206
-0.5% -$4.18K ﹤0.01% 1518
2021
Q3
$863K Hold
43,873
﹤0.01% 1531
2021
Q2
$965K Sell
43,873
-41,119
-48% -$915K ﹤0.01% 1493
2021
Q1
$2.02M Sell
84,992
-27,302
-24% -$729K ﹤0.01% 1091
2020
Q4
$2.94M Buy
112,294
+9,370
+9% +$197K 0.01% 992
2020
Q3
$1.79M Hold
102,924
﹤0.01% 1064
2020
Q2
$1.73M Hold
102,924
﹤0.01% 1054
2020
Q1
$1.22M Buy
102,924
+54,761
+114% +$678K ﹤0.01% 1102
2019
Q4
$583K Hold
48,163
﹤0.01% 1645
2019
Q3
$681K Hold
48,163
﹤0.01% 1545
2019
Q2
$537K Hold
48,163
﹤0.01% 1690
2019
Q1
$565K Hold
48,163
﹤0.01% 1699
2018
Q4
$643K Hold
48,163
﹤0.01% 1600
2018
Q3
$675K Hold
48,163
﹤0.01% 1705
2018
Q2
$757K Sell
48,163
-3,000
-6% -$52.2K ﹤0.01% 1644
2018
Q1
$842K Buy
51,163
+2,450
+5% +$45.4K ﹤0.01% 1546
2017
Q4
$880K Buy
48,713
+3,900
+9% +$70.6K ﹤0.01% 1541
2017
Q3
$865K Buy
44,813
+5,150
+13% +$76.8K ﹤0.01% 1577
2017
Q2
$468K Buy
39,663
+15,935
+67% +$173K ﹤0.01% 1895
2017
Q1
$260K Hold
23,728
﹤0.01% 2130
2016
Q4
$172K Hold
23,728
﹤0.01% 2271
2016
Q3
$154K Hold
23,728
﹤0.01% 2287
2016
Q2
$130K Hold
23,728
﹤0.01% 2293
2016
Q1
$111K Hold
23,728
﹤0.01% 2324
2015
Q4
$118K Sell
23,728
-7,533
-24% -$34K ﹤0.01% 2362
2015
Q3
$118K Buy
31,261
+20,540
+192% +$104K ﹤0.01% 2362
2015
Q2
$64K Hold
10,721
﹤0.01% 2426
2015
Q1
$60K Hold
10,721
﹤0.01% 2450
2014
Q4
$32K Hold
10,721
﹤0.01% 2493
2014
Q3
$29K Hold
10,721
﹤0.01% 2495
2014
Q2
$30K Hold
10,721
﹤0.01% 2514
2014
Q1
$47K Hold
10,721
﹤0.01% 2478
2013
Q4
$35K Hold
10,721
﹤0.01% 2503
2013
Q3
$17K Hold
10,721
﹤0.01% 2526
2013
Q2
$19K Buy
+10,721
New +$19.3K ﹤0.01% 2572

Other funds holding CORT

State Board of Administration of Florida Retirement System's CORT Position: Q2 2026 in Review

State Board of Administration of Florida Retirement System increased its Corcept Therapeutics (CORT) stake by 1.1% in Q2 2026, buying an estimated $49.2K and bringing the position to 73,222 shares worth $6.37M. The position accounts for 0.01% of the portfolio, ranked #755.

State Board of Administration of Florida Retirement System first reported a position in CORT in Q2 2013 and has held it in 53 quarters since. 205 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • State Board of Administration of Florida Retirement System held 73,222 shares of Corcept Therapeutics worth $6.37M as of Q2 2026.
  • State Board of Administration of Florida Retirement System bought 815 Corcept Therapeutics shares in Q2 2026, an estimated $49.2K.
  • Corcept Therapeutics made up 0.01% of State Board of Administration of Florida Retirement System's portfolio in Q2 2026, its #755 holding.
  • State Board of Administration of Florida Retirement System first reported a position in Corcept Therapeutics in Q2 2013 and has held it in 53 quarters since.
  • 205 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2026, filed 10 Aug 2026.